REQUEST A DEMO
Total
USD $0.00
Search more companies

Implatec S.A.S. (Colombia)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Implatec S.A.S. Profile Updated: April 05, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Implatec S.A.S. is a company based in Colombia, with its head office in Envigado. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was incorporated on April 27, 2000. There are currently 5 (2026) people employed by Implatec S.A.S.. From the latest financial highlights, Implatec S.A.S. reported a net sales revenue increase of 10.21% in 2025. Its’ total assets recorded a growth of 24.98%. The net profit margin of Implatec S.A.S. increased by 1.15% in 2025.

Headquarters
Cr 43A # 27A Sur 86 Lc 121 y 122
Envigado; Antioquia;

Contact Details: Purchase the Implatec S.A.S. report to view the information.

Website: http://implatec.com

Basic Information
Total Employees:
Purchase the Implatec S.A.S. report to view the information.
Financial Auditors:
Purchase the Implatec S.A.S. report to view the information.
Incorporation Date:
April 27, 2000
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Implatec S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
10.21%
Total Operating Revenue
10.21%
EBITDA
41.97%
Net Profit/Loss for the Period
39.82%
Total Assets
24.98%
Total Equity
29.2%
Net Profit Margin
1.15%
Return on Equity (ROE)
1.71%
Quick Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?